- Home
- VIRX vs TRUG Comparison
VIRX vs TRUG Comparison
Compare VIRX & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRX
- TRUG
- Stock Information
- Founded
- VIRX 2007
- TRUG 1983
- Country
- VIRX United States
- TRUG United States
- Employees
- VIRX N/A
- TRUG N/A
- Industry
- VIRX Biotechnology: Pharmaceutical Preparations
- TRUG
- Sector
- VIRX Health Care
- TRUG
- Exchange
- VIRX Nasdaq
- TRUG NYSE
- Market Cap
- VIRX 7.7M
- TRUG 6.4M
- IPO Year
- VIRX N/A
- TRUG N/A
- Fundamental
- Price
- VIRX $0.16
- TRUG $0.43
- Analyst Decision
- VIRX Buy
- TRUG
- Analyst Count
- VIRX 4
- TRUG 0
- Target Price
- VIRX $5.00
- TRUG N/A
- AVG Volume (30 Days)
- VIRX 2.5M
- TRUG 394.4K
- Earning Date
- VIRX 11-13-2024
- TRUG 11-14-2024
- Dividend Yield
- VIRX N/A
- TRUG N/A
- EPS Growth
- VIRX N/A
- TRUG N/A
- EPS
- VIRX N/A
- TRUG N/A
- Revenue
- VIRX N/A
- TRUG $21,917,131.00
- Revenue This Year
- VIRX N/A
- TRUG N/A
- Revenue Next Year
- VIRX N/A
- TRUG N/A
- P/E Ratio
- VIRX N/A
- TRUG N/A
- Revenue Growth
- VIRX N/A
- TRUG 7.68
- 52 Week Low
- VIRX $0.13
- TRUG $0.35
- 52 Week High
- VIRX $1.31
- TRUG $11.82
- Technical
- Relative Strength Index (RSI)
- VIRX 32.53
- TRUG 28.20
- Support Level
- VIRX $0.14
- TRUG $0.40
- Resistance Level
- VIRX $0.21
- TRUG $0.52
- Average True Range (ATR)
- VIRX 0.01
- TRUG 0.09
- MACD
- VIRX -0.00
- TRUG 0.01
- Stochastic Oscillator
- VIRX 43.86
- TRUG 28.20
About VIRX Viracta Therapeutics Inc.
Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The product candidate of the company is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people with organ transplants.
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.